Oral Abstracts
Please find your presentation information below.
| Thursday, March 23 |
| Presentation Time |
Presenting Author |
Oral Number |
Abstract Title |
| 10:00 - 10:10 AM |
Prachi Godiwala |
O1
|
A DOUBLE-BLINDED PROSPECTIVE RANDOMIZED TRIAL COMPARING EUPLOIDY RATES AMONG EMBRYOS CREATED FROM SIBLING OOCYTES INJECTED WITH SPERM PROCESSED BY MICROFLUIDICS OR BY DENSITY GRADIENT CENTRIFUGATION.
|
| 10:15 - 10:25 AM |
Fernanda Murillo
|
O2
|
CAUSAL INFERENCE INDICATES THAT POOR RESPONDERS GOING THROUGH A REPEAT CYCLE HAVE COMPARABLE OR BETTER OUTCOMES WITH ANTAGONIST PROTOCOL COMPARED TO FLARE
|
| 10:30 - 10:40 AM |
Rachel Mandelbaum |
O3
|
CLOMIPHENE CITRATE THROUGHOUT THE DURATION OF OVARIAN STIMULATION: AN APPROACH TO DECREASE COSTS, REDUCE INJECTION BURDEN, AND PREVENT PREMATURE OVULATION IN PATIENTS WITH DIMINISHED OVARIAN RESERVE |
| 10:45 - 10:55 AM |
Kate Devine
|
O4
|
DOES THE USE OF GNRH ANTAGONIST FOR OPTIMIZING TRANSFER DAY DECREASE SUCCESS IN MODIFIED NATURAL CYCLE FROZEN EMBRYO TRANSFERS? |
| 11:00 - 11:10 AM |
Joginder Bidhan |
O5
|
EFFECT OF LENGTH OF TIME POST-MORTEM ON QUALITY AND FREEZING CAPACITY OF HUMAN TESTICULAR SPERMATOZOA
|
| Friday, March 24 |
| Presentation Time |
Presenting Author |
Oral Number |
Abstract Title |
| 10:00 - 10:10 AM |
Matthew VerMilyea |
O6
|
EMBRYO SEX IDENTIFICATION THROUGH A NON-INVASIVE ARTIFICIAL INTELLIGENCE (AI) ALGORITHM
|
| 10:15 - 10:25 AM |
Michael Neblett
|
O7
|
EVALUATION OF THE IN VIVO EFFICACY OF THE JAK INHIBITOR AZD1480 AGAINST UTERINE LEIOMYOMAS IN A PATIENT-DERIVED XENOGRAFT MOUSE MODEL
|
| 10:30 - 10:40 AM |
Katherine Scott
|
O8
|
EXPLAINING FAILED EUPLOID BASTOCYST TRANSFER: ENHANCED DETECTION OF SEGMENTAL ABNORMALITIES USING HIGH DENSITY TARGETED AMPLIFICATION
|
| 10:45 - 10:55 AM |
Arian Khorshid |
O9
|
MOSAIC EMBRYO TRANSFER VERSUS ADDITIONAL IVF WITH PGTA CYCLE: A DECISION MODEL COMPARING LIVE BIRTH RATE AND COST
|
| 11:00 - 11:10 AM |
Amanda Schwartz |
O10
|
SHORT AND LONG-TERM TESTOSTERONE ADMINISTRATION IMPAIRS IN VITRO FERTILIZATION OUTCOMES WITH IMPROVEMENT FOLLOWING A WASHOUT PERIOD IN A MOUSE MODEL OF GENDER-AFFIRMING HORMONE CARE |
|
